Clenbuterol pills 0.02mg №50

Release form, composition and packaging

Pills round flat with a facet and dividing risk on the one hand, white or almost white.

Excipients: lactose monohydrate 70 mg, wheat starch 31.48 mg, microcrystalline cellulose 48.5 mg, colloidal silicon dioxide 2 mg, Magnesium stearate 2 mg, povidone (povidone K25) 6 mg.

Indications

Prevention and relief of bronchospasm in bronchial asthma; bronchitis with broncho-obstructive syndrome.

Dosing regimen

Is taken orally at a dose of 2.5-20 mg 2 times / day. The dose is set depending on the age of the patient and the clinical situation.

Side effect

Cardiovascular: tachycardia, extrasystole, lowering blood pressure.

From the side of the central nervous system: trembling fingers, anxiety, headache.

Gastrointestinal: dry mouth, nausea.

Allergic reactions: appearance of skin rash.

Other: hypokalemia.

Contraindications

Thyrotoxicosis, tachycardia, tachyarrhythmia, subaortic aortic stenosis, acute period of myocardial infarction, pregnancy, hypersensitivity to Clenbuterol.

Use during pregnancy and lactation

Contraindicated for use in pregnancy.

special instructions

Development of resistance and rebound syndrome is possible.

Do not allow contact with the drug in the eye, especially with glaucoma.

Drug interaction

Beta-blockers are pharmacological antagonists of clenbuterol and can eliminate its effect.

Clenbuterol reduces the effects of hypoglycemic agents. Increases the risk of developing intracardiac conduction disorders, while the appointment with MAO inhibitors and theophylline. Increases the toxicity of cardiac glycosides and increases the risk of arrhythmias. In combination with sympathomimetic agents, a mutual increase in toxicity occurs.